Strategic leadership Nutra-Med recently appointed a new CEO, signaling potential strategic pivots, growth initiatives, and a likely openness to new partnerships and contract arrangements that could align with outside clinical, regulatory, or manufacturing capabilities.

Expansion potential The acquisition of Legacy Pharma Solutions in 2017 suggests a track record of inorganic growth and capability expansion; identify opportunities to introduce enhanced packaging services or cross-sell to Legacy-tinged customers and broaden service offerings in contract packaging.

Scale and capability With 51-200 employees and revenue in the tens of millions, Nutra-Med operates in a mid-market niche for Rx/OTC contract packaging, including serialization as a service and stability packaging—ideal for materials suppliers, ancillary services, and technology partners seeking mid-size manufacturer relationships.

Technology stack Utilizes ERP and analytics (SAP, NetSuite, Power BI) and CRM/marketing tools (HubSpot, 6sense) plus e-commerce for service-related transactions; cross-sell opportunities exist with suppliers of serialization, regulatory data management, and cold chain packaging technology.

Market positioning Focused on small to mid-sized pharmaceutical, nutritional, and healthcare product packaging, with capabilities across thermo and cold blistering, bottling, pouching, cartoning, clinical and serialization services; target mid-market pharma brands seeking scalable, compliant packaging partners.